News
GSK ends decades-long hiatus in oral antibiotics for UTIs
The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review.
Friday 4 April 2025
